Compare HAS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAS | BME |
|---|---|---|
| Founded | 1923 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 499.8M |
| IPO Year | 1994 | 2005 |
| Metric | HAS | BME |
|---|---|---|
| Price | $96.95 | $39.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $109.73 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 52.6K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $5,365,900,000.00 | N/A |
| Revenue This Year | $5.38 | N/A |
| Revenue Next Year | $6.48 | N/A |
| P/E Ratio | $67.42 | ★ N/A |
| Revenue Growth | ★ 13.06 | N/A |
| 52 Week Low | $64.74 | $35.03 |
| 52 Week High | $106.98 | $42.74 |
| Indicator | HAS | BME |
|---|---|---|
| Relative Strength Index (RSI) | 54.36 | 47.15 |
| Support Level | $87.67 | $37.71 |
| Resistance Level | $98.70 | $39.52 |
| Average True Range (ATR) | 2.46 | 0.49 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 64.63 | 40.21 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.